Waddell & Reed Financial’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$152M Sell
476,711
-86,738
-15% -$27.8M 0.31% 81
2020
Q4
$183M Buy
563,449
+41,091
+8% +$11.4M 0.39% 66
2020
Q3
$145M Buy
522,358
+38,164
+8% +$11M 0.35% 68
2020
Q2
$117M Sell
484,194
-2,467
-0.5% -$495K 0.3% 89
2020
Q1
$70.6M Buy
486,661
+43,962
+10% +$7.3M 0.23% 120
2019
Q4
$75.5M Sell
442,699
-16,997
-4% -$3.15M 0.19% 151
2019
Q3
$81.8M Sell
459,696
-154,677
-25% -$33.4M 0.21% 134
2019
Q2
$160M Buy
614,373
+70,605
+13% +$18.7M 0.4% 66
2019
Q1
$155M Buy
543,768
+13,348
+3% +$4.44M 0.38% 67
2018
Q4
$172M Buy
530,420
+24,269
+5% +$8.43M 0.49% 49
2018
Q3
$228M Buy
506,151
+51,007
+11% +$20.1M 0.5% 44
2018
Q2
$186M Sell
455,144
-30,613
-6% -$11.1M 0.43% 58
2018
Q1
$141M Buy
485,757
+180,423
+59% +$45.7M 0.32% 82
2017
Q4
$57.2M Buy
305,334
+131,120
+75% +$24.5M 0.13% 189
2017
Q3
$29.4M Buy
+174,214
New +$26.3M 0.07% 287

Other funds holding ABMD